Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
ACS Medicinal Chemistry Letters
|
December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic Pain
Sangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2008
Novel H3 receptor antagonists with improved pharmacokinetic profiles
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry
|
August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomnia
Yifeng Xiong, Brett Ullman, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
Graeme Semple, Juerg Lehmann, Amy Wong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2011
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control
Graeme Semple, Albert Ren, Beatriz Fioravanti, et al.
Journal of Medicinal Chemistry
|
May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis
Yifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Identification of biaryl sulfone derivatives as antagonists of the histamine H₃ receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916)
Graeme Semple, Vincent J Santora, Jeffrey M Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 16, 2008
A new family of H3 receptor antagonists based on the natural product Conessine
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
ACS Medicinal Chemistry Letters
|
December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic Pain
Sangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2008
Novel H3 receptor antagonists with improved pharmacokinetic profiles
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
The Journal of Biological Chemistry
|
April 25, 2007
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov, et al.
Journal of Medicinal Chemistry
|
August 14, 2008
Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomnia
Yifeng Xiong, Brett Ullman, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile
Graeme Semple, Juerg Lehmann, Amy Wong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 30, 2011
Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control
Graeme Semple, Albert Ren, Beatriz Fioravanti, et al.
Journal of Medicinal Chemistry
|
May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis
Yifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2011
Identification of biaryl sulfone derivatives as antagonists of the histamine H₃ receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916)
Graeme Semple, Vincent J Santora, Jeffrey M Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 16, 2008
A new family of H3 receptor antagonists based on the natural product Conessine
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Page
of 6